World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
21527
World Ranking
1284
National Ranking
73

Vincent Calvez publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Vincent Calvez sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 468 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Vincent Calvez D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Vincent Calvez sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Vincent Calvez is a researcher affiliated with the Centre national de la recherche scientifique (CNRS) in France. Their scholarly work primarily spans the field of Medicine, with a strong focus on Infectious Diseases, Epidemiology, Virology, Genetics, and Molecular Biology.

The scientist has contributed to research across several main topics including:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • Evolution and Genetic Dynamics
  • Viral-associated cancers and disorders

Frequent publication venues for Vincent Calvez include:

  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Infection
  • Clinical Infectious Diseases
  • Microbiology Spectrum

Notable recent papers authored or coauthored by Vincent Calvez are:

  • "2025 update of the drug resistance mutations in HIV-1," 2025, PubMed
  • "Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers," 2021, Nature Communications
  • "The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients," 2021, Journal of Infection
  • "Viral loads in clinical samples of men with monkeypox virus infection: a French case series," 2022, The Lancet Infectious Diseases
  • "Evolution of viral quasispecies during SARS-CoV-2 infection," 2020, Clinical Microbiology and Infection

Vincent Calvez has collaborated extensively with several frequent coauthors including Anne-Geneviève Marcelin, Stéphane Marot, Aude Jary, Cathia Soulié, and Marc Wirden. These collaborations reflect a multidisciplinary approach within infectious disease and virology research.

Best Publications

  • 2017 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

    TS Li;R Tubiana;C Katlama;V Calvez

  • 2015 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy

    D Descamps;P Flandre;V Calvez;G Peytavin

  • Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.

    N. Dupin;M. Grandadam;V. Calvez;J.T. Aubin

  • Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

    Y Benhamou;M Bochet;V Thibault;V Calvez

  • Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

    Isabelle Malet;Olivier Delelis;Marc-Antoine Valantin;Brigitte Montes

  • Update of the drug resistance mutations in HIV-1: March 2013.

    Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  • Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

    Anne-Marie Taburet;Christophe Piketty;Corine Chazallon;Isabelle Vincent

  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

    Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  • Directional persistence of chemotactic bacteria in a traveling concentration wave

    Jonathan Saragosti;Vincent Calvez;Nikolaos Bournaveas;Benoît Perthame

  • HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment

    Avidan U. Neumann;Roland Tubiana;Vincent Calvez;Catherine Robert

  • Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Günthard;Vincent Calvez;Roger Paredes;Deenan Pillay

  • Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.

    Fernanda Grassi;Anne Hosmalin;Dorian McIlroy;Vincent Calvez

  • Rituximab therapy for HIV-associated Castleman disease.

    Anne-Geneviève Marcelin;Laurent Aaron;Christine Mateus;Emmanuel Gyan

  • Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.

    Guislaine Carcelain;Roland Tubiana;Assia Samri;Vincent Calvez

  • Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-κB and MAPK pathways

    Philippe A. Grange;Joël Raingeaud;Vincent Calvez;Nicolas Dupin

  • Restoration of the immune system with anti-retroviral therapy.

    Brigitte Autran;Guislaine Carcelaint;Taisheng S. Li;Guy Gorochov

  • Exacerbations of Clinical Symptoms in Human Immunodeficiency Virus Type 1—Infected Patients with Multicentric Castleman's Disease Are Associated with a High Increase in Kaposi's Sarcoma Herpesvirus DNA Load in Peripheral Blood Mononuclear Cells

    Marc Grandadam;Nicolas Dupin;Vincent Calvez;Isabelle Gorin

  • Diagnosing Treponema pallidum in Secondary Syphilis by PCR and Immunohistochemistry

    Marc Buffet;Philippe A. Grange;Philippe Gerhardt;Agnès Carlotti

  • Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

    Stéphane Marot;Isabelle Malet;Valentin Leducq;Karen Zafilaza

  • Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

    C. Delaugerre;R. Rohban;A. Simon;M. Mouroux

Frequent Co-Authors

Christine Katlama
Christine Katlama Sorbonne University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Nicolas Dupin
Nicolas Dupin Université Paris Cité
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Henri Agut
Henri Agut Sorbonne University
Guislaine Carcelain
Guislaine Carcelain Université Paris Cité
Brigitte Autran
Brigitte Autran Sorbonne University
Benoît Perthame
Benoît Perthame Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related fields with strong career potential. For example, pursuing a healthcare-related bachelor's degree can lead to roles like a child life specialist, where understanding biology and patient care is essential. To learn more about earning potential in this field, see the child life specialist salary with bachelor degree.

For those with unique challenges, such as felons looking to rebuild their careers, there are accessible options. Microbiology and allied health sciences can be part of the list of degrees felons can get, offering a meaningful path into science-based professions with flexible online learning opportunities.

Additionally, combining microbiology knowledge with nursing opens paths like becoming a functional medicine nurse practitioner. This role emphasizes holistic and evidence-based patient care, supported by a solid science background. For insight into the financial outlook, check the functional medicine nurse practitioner salary.

Beyond direct healthcare roles, certifications such as CPC (Certified Professional Coder) also complement microbiology studies by enhancing job prospects in medical billing and coding. This specialization offers competitive earning potential as outlined in the cpc certification salary overview.

Best Scientists Citing Vincent Calvez

Trending Scientists

Recently Published Articles